NO993684L - Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II - Google Patents

Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II

Info

Publication number
NO993684L
NO993684L NO993684A NO993684A NO993684L NO 993684 L NO993684 L NO 993684L NO 993684 A NO993684 A NO 993684A NO 993684 A NO993684 A NO 993684A NO 993684 L NO993684 L NO 993684L
Authority
NO
Norway
Prior art keywords
amino acid
stands
residue
gly
peptides
Prior art date
Application number
NO993684A
Other languages
English (en)
Other versions
NO993684D0 (no
Inventor
Sinasi Bayrak
Rikard Holmdahl
Avrion Mitchison
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO993684D0 publication Critical patent/NO993684D0/no
Publication of NO993684L publication Critical patent/NO993684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer et isolert peptid som omfatter en aminosyrese- kvens med formelen (I) A,-Xaa-Gly-A4-A5-Gly-A7-Xaa-Gly, hvori A, står for en ami- nosyrerest med en aromatisk eller alifatisk sidekjede, A4 står for en asparagin- eller ar- gininrest eller en aminosyrerest med en aromatisk eller alifatisk sidekjede, A5 står for enhver naturlig forekommende aminosyre, A7 står for en aminosyre med en negativt ladet rest, Xaa står for enhver aminosyrerest, og Gly står for en glysinrest; og anvendel- sen av slike peptider i medisinsk terapi, spesielt i behandlingen av autoimmune tilstan- der slik som reumatoid artritt.
NO993684A 1997-01-31 1999-07-29 Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II NO993684L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700301A SE9700301D0 (sv) 1997-01-31 1997-01-31 New compound
PCT/SE1998/000128 WO1998033811A1 (en) 1997-01-31 1998-01-29 Peptides comprising a t-cell epitope specific to collagen ii

Publications (2)

Publication Number Publication Date
NO993684D0 NO993684D0 (no) 1999-07-29
NO993684L true NO993684L (no) 1999-09-02

Family

ID=20405590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993684A NO993684L (no) 1997-01-31 1999-07-29 Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II

Country Status (19)

Country Link
EP (1) EP1007547A1 (no)
JP (1) JP2001511143A (no)
KR (1) KR20000070542A (no)
CN (1) CN1246125A (no)
AU (1) AU744907B2 (no)
BR (1) BR9811250A (no)
CA (1) CA2278638A1 (no)
EE (1) EE9900334A (no)
HU (1) HUP0000836A3 (no)
ID (1) ID22802A (no)
IL (1) IL131045A0 (no)
IS (1) IS5138A (no)
NO (1) NO993684L (no)
NZ (1) NZ336745A (no)
PL (1) PL334877A1 (no)
SE (1) SE9700301D0 (no)
SK (1) SK102199A3 (no)
TR (1) TR199901831T2 (no)
WO (1) WO1998033811A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO571297A0 (en) * 1997-03-19 1997-04-10 Montech Medical Developments Pty Ltd Method for the diagnosis of rheumatoid arthritis
CA2452593C (en) 2001-07-12 2015-02-03 Arexis Ab Triple polypeptide complexes
MXPA04002348A (es) * 2001-09-14 2004-09-28 Biora Bioex Ab Composiciones de proteina de matriz de esmalte para modular respuesta inmune.
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
KR20170002734U (ko) 2016-01-21 2017-07-31 김인수 자동 목재절단 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08151396A (ja) * 1994-11-28 1996-06-11 Teijin Ltd Ｈｌａ結合性オリゴペプチド及びそれを含有する免疫調節剤
AU4695296A (en) * 1995-01-06 1996-07-24 Immulogic Pharmaceutical Corporation Compositions and methods for treating rheumatoid arthritis

Also Published As

Publication number Publication date
IL131045A0 (en) 2001-01-28
EP1007547A1 (en) 2000-06-14
HUP0000836A2 (hu) 2000-11-28
TR199901831T2 (xx) 1999-10-21
NZ336745A (en) 2001-09-28
HUP0000836A3 (en) 2001-04-28
JP2001511143A (ja) 2001-08-07
IS5138A (is) 1999-07-28
SE9700301D0 (sv) 1997-01-31
PL334877A1 (en) 2000-03-27
AU744907B2 (en) 2002-03-07
KR20000070542A (ko) 2000-11-25
ID22802A (id) 1999-12-09
EE9900334A (et) 2000-02-15
WO1998033811A1 (en) 1998-08-06
SK102199A3 (en) 2000-08-14
CN1246125A (zh) 2000-03-01
BR9811250A (pt) 2000-09-26
CA2278638A1 (en) 1998-08-06
AU5889298A (en) 1998-08-25
NO993684D0 (no) 1999-07-29

Similar Documents

Publication Publication Date Title
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
ATE338121T1 (de) Von muc-1 abgeleitete peptide
DK0750506T3 (da) Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse
EP0333356A3 (en) Hirudin peptides
TR200000649T2 (tr) PTHrP analogları kullanılarak kırıkların iyileştirilmesi.
AR008765A1 (es) Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del
IL69469A0 (en) Molecular cloning and characterization of a gene sequence coding for human relaxin
FI961044A0 (fi) Kininogeeni-inhibiittorit
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
SE9700301D0 (sv) New compound
WO2006046239A3 (en) A thymus-specific protein
GB0210783D0 (en) Anti-microbial polypeptides
EP0917535A4 (en) NEURO-ACTIVE PEPTIDE
DK137085A (da) Fremgangsmaade og mellemprodukter til fremstilling af racematfattigepeptider
EP0837074A3 (en) Biologically active fibronectin fragment as cancer metastasis inhibitor
AU7196596A (en) Peptides and antibodies for treatment of rheumatoid arthritis
AR026068A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia.
EP2143730A3 (en) Modified peptides and their use for the treatment of autoimmune diseases
IL122445A (en) Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis
NZ508812A (en) Peptides for the prevention or treatment of HIV
ATE393777T1 (de) Tachykininpeptide, ihre präpeptide und sie kodierende gene
AU2003303218A8 (en) Peptides and their use for the treatment of hiv infections
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application